According to the latest report by IMARC Group, titled "Post-Partum Depression Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2033," the global post-partum depression market size is witnessing steady growth. Post-partum depression refers to a mixture of complex emotional feelings and behavioral changes that occur in women after childbirth. It initiates within four weeks after the delivery of the child, and the diagnosis is based on the duration between the delivery and onset of depression and the severity of the symptoms. It is connected with chemical, social, and psychological modifications that take place in the body of a woman after delivering the baby. It is primarily caused by a rapid drop in the levels of estrogen and progesterone, which are essential female reproductive hormones. It also shows various other symptoms, such as mood swings, loss of appetite or eating more than usual, insomnia, tiredness, anger, panic attacks, and severe anxiety. Besides this, it is primarily examined by conducting depression screening and providing a questionnaire to women after childbirth.
Global Post-Partum Depression Market Trends:
At present, the increasing demand for post-partum depression management services and post-partum depression drugs due to the rising awareness about the experiences of mothers after childbirth represents one of the major factors influencing the market positively. Besides this, the growing occurrence of various pregnancy-associated risks, such as physical changes, regular sleep deprivation, and loneliness due to low or no social and family support after childbirth, is offering a favorable market outlook. In addition, the increasing availability of post-partum depression management practices by adopting healthy lifestyle habits and sharing responsibilities of the newly born child with other family members and between both parents is propelling the growth of the market. Additionally, the rising investments made by public and private pharmaceutical companies in research and development (R&D) activities to manufacture safe and effective drugs to cure post-partum depression are bolstering the growth of the market.
- Region-wise, the market has been classified into the United States, EU5 (Germany, France, the United Kingdom, Italy, and Spain), and Japan. The United States has the largest patient population for post-partum depression and also represents the largest market for its treatment among the seven major markets.
- This research study also offers a thorough overview of late-stage pipeline candidates and currently marketed medications for post-partum depression.
- The study also offers a thorough overview of the treatment practices for post-partum depression, the share of specific therapies, and the performance of key market players.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800